1979P Disitamab Vedotin (DV) Plus Toripalimab (T) in Unresectable Locally Advanced or Metastatic Urothelial Carcinoma (la/muc): Long-term Outcomes from a Phase Ib/II Study
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined